Population Pharmacokinetics of Tarlatamab, a Half-Life Extended DLL3-Directed Bispecific T-Cell Engager in Patients with Previously Treated Small Cell Lung Cancer
用户ZHpUxjhiFwbk
5天前
44
10
已完结
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2025-12-03 10:57:44 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1007/s40262-025-01499-z
文献链接: https://link.springer.com/10.1007/s40262-025-01499-z
其他信息:
出版社: Springer Science and Business Media LLC
作者: Stephanie Kong; Mukul Minocha; Po-Wei Chen; Pablo Martinez; Erik S. Anderson; Amanda Parkes; Brett E. Houk; Chih-Wei Lin
全文下载地址: https://link.springer.com/content/pdf/10.1007/s40262-025-01499-z.pdf
